Medications
Prolia
Brand: Amgen
Twice-yearly injectable antibody (denosumab) that blocks bone resorption to reduce fracture risk in osteoporosis.
Mentions
"prolio's denosimab that was 2010 was FDA approved. That's one shot twice a year."
Medications
Brand: Amgen
Twice-yearly injectable antibody (denosumab) that blocks bone resorption to reduce fracture risk in osteoporosis.
"prolio's denosimab that was 2010 was FDA approved. That's one shot twice a year."